Cathy Schilero

38.8k total citations
13 papers, 113 citations indexed

About

Cathy Schilero is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Cathy Schilero has authored 13 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Cathy Schilero's work include Glioma Diagnosis and Treatment (11 papers), Cancer Research and Treatments (4 papers) and Brain Metastases and Treatment (4 papers). Cathy Schilero is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Cancer Research and Treatments (4 papers) and Brain Metastases and Treatment (4 papers). Cathy Schilero collaborates with scholars based in United States. Cathy Schilero's co-authors include Manmeet S. Ahluwalia, David M. Peereboom, Glen Stevens, Paul Elson, Brian P. Hobbs, Andrew B. Nixon, Keith R. McCrae, Robert A. Fenstermaker, Michael J. Ciesielski and Mayur Sharma and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Neuro-Oncology.

In The Last Decade

Cathy Schilero

13 papers receiving 112 citations

Peers

Cathy Schilero

GENET

ONCOL

PRM

IMMUN

Elke Pfaff Germany

Francesco Grillone Italy

Jiangfen Zhou China

Jennifer A. Arzt United States

Hong L. Tiv United States

Von Potter United States

Felix Seyfried Germany

Anne Song United States

Karol Pál Czechia

Nancy Moore United States

Elke Pfaff Germany

Cathy Schilero

84 ×1.2

GENET

26 ×0.5

ONCOL

30 ×0.8

PRM

13 ×0.4

IMMUN

48 ×1.5

Citations per year, relative to Cathy Schilero Cathy Schilero (= 1×) peers Elke Pfaff

Countries citing papers authored by Cathy Schilero

Since Specialization

Citations

This map shows the geographic impact of Cathy Schilero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Schilero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Schilero more than expected).

Fields of papers citing papers by Cathy Schilero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Schilero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Schilero. The network helps show where Cathy Schilero may publish in the future.

Co-authorship network of co-authors of Cathy Schilero

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Schilero. A scholar is included among the top collaborators of Cathy Schilero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Schilero. Cathy Schilero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ciesielski, Michael J., Manmeet S. Ahluwalia, David A. Reardon, et al.. (2022). Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma.. Journal of Clinical Oncology. 40(16_suppl). 2037–2037. 6 indexed citations

Ahluwalia, Manmeet S., et al.. (2020). CTIM-10. PHASE II STUDY OF PEMBROLIZUMAB PLUS SurVaxM FOR GLIOBLASTOMA AT FIRST RECURRENCE. Neuro-Oncology. 22(Supplement_2). ii34–ii35. 3 indexed citations

Ahluwalia, Manmeet S., David M. Peereboom, Cathy Schilero, et al.. (2020). Phase II study of pembrolizumab plus SurVaxM for glioblastoma at first recurrence.. Journal of Clinical Oncology. 38(15_suppl). TPS2581–TPS2581. 10 indexed citations

Murphy, Erin S., Kailin Yang, John H. Suh, et al.. (2019). Prospective Phase I Dose Escalation Study for Neoadjuvant Radiosurgery for Large Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 105(1). S10–S11. 3 indexed citations

Sharma, Mayur, Cathy Schilero, David M. Peereboom, et al.. (2019). Phase II study of Dovitinib in recurrent glioblastoma. Journal of Neuro-Oncology. 144(2). 359–368. 34 indexed citations

Ahluwalia, Manmeet S., David A. Reardon, William T. Curry, et al.. (2019). SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.. Journal of Clinical Oncology. 37(15_suppl). 2016–2016. 17 indexed citations

Murphy, Erin S., Kailin Yang, John H. Suh, et al.. (2019). Early Results from a Prospective Phase II Dose Escalation Study for Neoadjuvant Radiosurgery for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 103(5). E5–E5. 3 indexed citations

Murphy, Erin S., Kailin Yang, John H. Suh, et al.. (2019). TRLS-05. EARLY RESULTS FROM A PROSPECTIVE PHASE I/II DOSE ESCALATION STUDY OF NEOADJUVANT RADIOSURGERY FOR BRAIN METASTASES. Neuro-Oncology Advances. 1(Supplement_1). i9–i9. 2 indexed citations

Ahluwalia, Manmeet S., David M. Peereboom, Cathy Schilero, et al.. (2018). RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA. Neuro-Oncology. 20(suppl_6). vi234–vi234. 4 indexed citations

10.

Ahluwalia, Manmeet S., David A. Reardon, William T. Curry, et al.. (2018). Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 36(15_suppl). 2041–2041. 2 indexed citations

11.

Ahluwalia, Manmeet S., David A. Reardon, William T. Curry, et al.. (2018). ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma. Neuro-Oncology. 20(suppl_6). vi10–vi11. 7 indexed citations

12.

Ahluwalia, Manmeet S., Samuel T. Chao, Michael Parsons, et al.. (2015). Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases. Journal of Neuro-Oncology. 124(3). 485–491. 17 indexed citations

13.

Ahluwalia, Manmeet S., Nikolaos Papadantonakis, Vyshak Alva Venur, et al.. (2015). Phase II trial of dovitinib in recurrent glioblastoma.. Journal of Clinical Oncology. 33(15_suppl). 2050–2050. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact